Lixte Biotechnology Files 8-K on Stock and Warrants
Ticker: LIXT · Form: 8-K · Filed: Jul 16, 2025 · CIK: 1335105
| Field | Detail |
|---|---|
| Company | Lixte Biotechnology Holdings, INC. (LIXT) |
| Form Type | 8-K |
| Filed Date | Jul 16, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-action, stock-event
Related Tickers: LIXT
TL;DR
LIXT filed an 8-K on July 16th about stock and warrant changes.
AI Summary
Lixte Biotechnology Holdings, Inc. filed an 8-K on July 16, 2025, reporting an event that occurred on July 15, 2025. The filing indicates changes related to its common stock and warrants to purchase common stock. The company is incorporated in Delaware and its principal executive offices are located in Pasadena, California.
Why It Matters
This filing provides updates on the company's capital structure, specifically concerning its common stock and warrants, which could impact investors and the stock's trading dynamics.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of corporate events and does not appear to contain significant negative financial or operational news.
Key Players & Entities
- LIXTE BIOTECHNOLOGY HOLDINGS, INC. (company) — Registrant
- July 16, 2025 (date) — Filing date
- July 15, 2025 (date) — Earliest event reported date
- 001-39717 (other) — Commission File Number
- 20-2903526 (other) — I.R.S. Employer Identification Number
FAQ
What specific event occurred on July 15, 2025, that prompted this 8-K filing?
The filing does not specify the exact event but indicates it relates to 'Other Events' and 'Financial Statements and Exhibits', and involves changes to common stock and warrants.
What is the par value per share for Lixte Biotechnology's common stock and warrants?
The par value per share for both common stock and warrants to purchase common stock is $0.0001.
Where are Lixte Biotechnology's principal executive offices located?
The principal executive offices are located at 680 East Colorado Boulevard, Suite 180, Pasadena, California 91101.
In which state was Lixte Biotechnology Holdings, Inc. incorporated?
Lixte Biotechnology Holdings, Inc. was incorporated in Delaware.
What is the company's fiscal year end?
The company's fiscal year end is December 31st.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 16, 2025 regarding LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT).